Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Banc Of America Health Care Conference In Brief

This article was originally published in The Gray Sheet

Executive Summary

St. Jude on consolidation: Potential product bundling in the wake of a planned J&J/Guidant merger warrants attention from the Federal Trade Commission and European antitrust authorities, St. Jude President & CEO Daniel Starks maintained at the Banc of America Health Care Conference May 17. "We are terribly concerned by it," Starks said of the deal, expected to close in Q3. Starks acknowledged that St. Jude had previously signed a collaborative marketing pact with J&J for product bundling, but that customers were not interested...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022160

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel